Global Mammography Devices Market – Industry Trends and Forecast to 2031

Mammography Devices Market Analysis and Size

According to the 2022 Globocan report, breast cancer stands out as the second most frequently diagnosed cancer globally, constituting 11.6% of all cancer cases worldwide. This widespread prevalence serves as a primary driver for the growth of the mammography devices market. Mammography devices play a pivotal role in the realm of medical imaging, specifically designed for the early detection and precise diagnosis of breast cancer. The high incidence rate necessitates frequent and widespread screening programs, increasing the demand for mammography devices across healthcare facilities worldwide. These devices are essential tools for early detection, enabling healthcare providers to identify breast cancer at its earliest and most treatable stages.

Global mammography devices market size was valued at USD 2.31 billion in 2023 and is projected to reach USD 5.68 billion by 2031, with a CAGR of 11.9% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

Mammography devices are specialized medical imaging systems used for the early detection and diagnosis of breast cancer. These devices utilize low-dose X-rays to create detailed images of the breast tissue, known as mammograms, which can reveal abnormal growths or changes in breast tissue. Mammography devices include film screen systems, digital systems, 3D systems (such as digital breast tomosynthesis), analog systems, and biopsy systems.             

Mammography Devices Market Dynamics

Drivers

• Increasing Incidence of Breast Cancer      

As breast cancer remains one of the most common cancers affecting women worldwide, the need for effective screening methods is more crucial than ever. Mammography is a proven technique for early detection, which is vital for successful treatment outcomes. According to the Mammography Quality Standards Act (MQSA) National Statistics of the U.S., as of August 2022, there were approximately 39.5 million mammography procedures, compared to 38.6 million procedures in August 2021. Consequently, healthcare systems and providers are increasingly prioritizing the adoption of advanced mammography devices to meet the growing demand for reliable diagnostic solutions. This surge in breast cancer cases underscores the critical role of mammography devices in enhancing early diagnosis and improving patient survival rates. The rising incidence of breast cancer globally is significantly driving the demand for early detection and diagnostic tools, including mammography devices.     

• Rising Healthcare Expenditure    

With government and private entities allocating more resources to improve healthcare facilities, there is a growing emphasis on incorporating state-of-the-art diagnostic equipment. Advanced mammography devices, with their enhanced imaging capabilities and diagnostic accuracy, are becoming integral components of modern healthcare setups. This trend is particularly evident in developed regions, where substantial healthcare budgets support the continuous upgrade of medical technologies. The rising healthcare expenditure thus fosters the growth of the mammography devices market by ensuring that healthcare providers have access to the latest diagnostic tools. Increasing investments in healthcare infrastructure and services are leading to the widespread adoption of advanced mammography devices in hospitals and clinics.

Opportunities

• Technological Innovations in Mammography Technology     

Continuous innovations in mammography technology, such as 3D mammography and digital breast tomosynthesis, are significantly enhancing the accuracy and efficiency of breast cancer detection. These technological advancements allow for more detailed and precise imaging of breast tissue, which helps in identifying abnormalities at an earlier stage. 3D mammography, for instance, provides a multi-layered view of the breast, reducing the chances of false positives and negatives. Digital breast tomosynthesis offers a clearer and more comprehensive picture, aiding radiologists in making more accurate diagnoses. These cutting-edge technologies not only improve diagnostic outcomes but also enhance patient comfort and experience, creating new opportunities in the market.       

• Portable and Affordable Mammography Devices  

Developing portable and cost-effective mammography devices can significantly enhance accessibility, particularly in underserved regions. In many parts of the world, especially in rural and low-income areas, access to advanced medical imaging equipment is limited. Portable mammography devices can bridge this gap by providing mobile screening solutions that can be deployed in remote locations. Additionally, making these devices more affordable ensures that a larger segment of the population can benefit from early breast cancer detection. These innovations in portability and affordability are crucial for expanding the reach of mammography services and improving public health outcomes.

Restraints/Challenges

• Radiation Exposure Concerns     

The potential risks associated with radiation exposure during mammography can deter some women from undergoing regular screenings. Despite the low levels of radiation used in mammography, concerns about cumulative exposure and its long-term effects can lead to hesitancy among patients. This apprehension can negatively impact the uptake of mammography screening programs, ultimately affecting early detection rates and challenging the market growth.        

• High Cost of Mammography Devices  

The mammography device price can be a significant barrier for healthcare facilities, particularly in developing regions. State-of-the-art mammography systems, while offering superior imaging capabilities, often come with substantial price tags that can strain the budgets of hospitals and clinics with limited financial resources. This financial hurdle can impede the widespread adoption of advanced diagnostic tools, restricting access to high-quality breast cancer screening for many patients.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In June 2024, the Healthcare Division of FUJIFILM India, in partnership with NM Medical Mumbai, launched its first Fujifilm Skill Lab. This initiative aims to provide advanced training in full-field digital mammography (FFDM) technologies for radiologists and radiographers. The inaugural session was attended by eight participants, including four radiologists and four radiographers           
• In September 2023, Siemens Healthineers introduced the Mammomat B.brilliant1, a new mammography system featuring wide-angle tomosynthesis. This system boasts the largest angle available on the market, with the tube moving around the breast at a 50° angle. Coupled with a scan time of approximately five seconds, it offers the fastest wide-angle tomosynthesis available, producing high-resolution 3D images with remarkable depth in minimal time

Mammography Devices Market Scope

The market is segmented on the basis of device type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

• Analog
• Digital
  • Full Field Systems
  • Breast Tomosynthesis Systems
  • Combination Systems
• Others

End User

• Hospitals
• Specialty Clinics
• Diagnostic Centers

Mammography Devices Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, device type, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the increasing incidence of breast cancer, a growing female population, heightened awareness of preventive breast cancer screenings, rising healthcare expenditures, and the expanding healthcare sector in the region.     

Asia-Pacific is expected to witness significant growth during the forecast period due to the high prevalence of breast cancer, advancements in breast imaging technologies, and increasing awareness of preventive screenings for breast cancer.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Mammography Devices Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• FUJIFILM Holdings Corporation (Japan)
• Hologic, Inc. (U.S.)
• Siemens Healthcare Private Limited (Germany)
• PLANMED OY (Finland)
• Metaltronica S.p.A. (Italy)
• AURORA HEALTHCARE US CORP (U.S.)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Analogic Corporation (U.S.)
• Carestream Health (U.S.)
• General Electric Company (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• CMR Naviscan (U.S.)
• Delphinus Medical Technologies, Inc. (U.S.)
• KUB Technologies (U.S.)
• Micrima Limited (U.K.)
• SonoCiné (U.S.)
• Supersonic Imagine (France)

SKU-1358